Trial
NCT00907179
Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
Novartis Pharmaceuticals
Condition
Non-Small Cell Lung Cancer
Intervention
LBH 589
Why stopped
Widespread use firstline Pemetrexed; slow recruitment; funding withdrawn..
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-22